Asymptomatic severe aortic stenosis: Cardiopulmonary exercise testing in “The World of AVATAR”

2016 ◽  
Vol 178 ◽  
pp. e1 ◽  
Author(s):  
Alberto Dominguez-Rodriguez ◽  
Pedro Abreu-Gonzalez
2016 ◽  
Vol 178 ◽  
pp. e3-e4 ◽  
Author(s):  
Marko Banovic ◽  
Bernard Iung ◽  
Jozef Bartunek ◽  
Martin Penicka ◽  
Guy van Camp ◽  
...  

2014 ◽  
Vol 107 (10) ◽  
pp. 519-528 ◽  
Author(s):  
Franck Levy ◽  
Nader Fayad ◽  
Antoine Jeu ◽  
Dominique Choquet ◽  
Catherine Szymanski ◽  
...  

2019 ◽  
Vol 73 (9) ◽  
pp. 1957
Author(s):  
Sonia Fortin ◽  
Vuyisile Nkomo ◽  
Maria I. Barillas Lara ◽  
Yazan Assaf ◽  
Amanda Bonikowske ◽  
...  

2020 ◽  
Author(s):  
Belén Marí-López ◽  
María Manuela Izquierdo-Gómez ◽  
Ignacio Laynez-Cerdeña ◽  
Amelia Duque-González ◽  
Leopoldo Pérez de Isla ◽  
...  

Abstract Background The clinical behavior and prognosis of patients with asymptomatic paradoxical low-gradient aortic stenosis (PLGAS) still remain controversial. Some authors consider PLGAS as an echocardiographically poorly quantified moderate AS (MAS). We aimed to investigate the clinical behavior of PLGAS by comparing it with that of asymptomatic high-gradient aortic stenosis (HG-AS) and MAS using transthoracic echocardiography (TTE) with speckle tracking imaging (STI) and cardiopulmonary exercise testing (CPET).Methods A cohort of 113 patients was included and categorized into three groups according to AS type: MAS (n=63), HG-AS (n=29), and PLGAS (n=21). Patients’ clinical data were obtained. Patients underwent 2D TTE with STI and CPET. Results There were no significant differences in the clinical variables between the three AS groups. In the multivariate multinomial logistic regression analysis, with PLGAS being the reference category, the most powerful variable for establishing a difference with HG-AS was the left ventricular mass (LVM) indexed by body-surface area (odds ratio [OR]=1.04, confidence interval [CI]=1.01-1.06, p<0.05). The MAS group showed a lower valvuloarterial impedance (OR=0.262, CI=0.12-0.59, p=0.001), fewer abnormal CPET (OR=0.198, CI=0.06-0.69, p<0.05), and higher left ventricle global longitudinal strain rate (GLSR) (OR=0.003, CI=0.00-0.35, p<0.05) than the PLGAS group.Conclusions TTE with STI and CPET established the clear differences between patients with asymptomatic PLGAS and those with asymptomatic MAS, as well as the similarities between patients with PLGAS and those with HG-AS. Our data identifies PLGAS as a completely different entity from MAS.


2017 ◽  
Vol 227 ◽  
pp. 908-914 ◽  
Author(s):  
Olivia Domanski ◽  
Marjorie Richardson ◽  
Augustin Coisne ◽  
Anne-Sophie Polge ◽  
Stephanie Mouton ◽  
...  

Circulation ◽  
2014 ◽  
Vol 130 (suppl_2) ◽  
Author(s):  
Van D Le ◽  
Gunnar V Jensen ◽  
Steen Carstensen ◽  
Lars Kjoller-Hansen

Objective: To access the prognostic value of cardiopulmonary exercise testing (CPX) in patients with asymptomatic or equivocal symptomatic aortic stenosis (AS/ES-AS). Methods: Patients with AS/ES-AS without left ventricular dysfunction were prospectively grouped according to their CPX outcome: 1) peak oxygen-consumption (pVO 2 ) >83% and peak oxygen-pulse (pO 2 pulse) >95% of that predicted; 2) pVO 2 <83% or pO 2 pulse <95% but CPX pointing to other cause than hemodynamic compromise; 3) pVO 2 <83% and respiratory coefficient >1 or clear exercise-limiting discomfort. At baseline Groups 1 (n=77) and 2 (n=35) were handled conservatively and Group 3 (n=18) referred for aortic valve replacement (AVR). Primary end-point was cardiac death, hospitalization with heart failure or AVR with improvement from just pre-AVR to nine months post-AVR in pVO 2 or Physical Component Score from the SF-36 > the estimated clinical relevant difference (5% and 7.5%, respectively). Results: The mean age, valve area and follow-up was 72.1±6.9 years, 0.45±0.11 cm/m 2 and 24±5 months, respectively; 48% were NYHA class ≥II. The end-point was reached in 25.3%, 26.4% and 62.5% in Group 1, 2 and 3, respectively (Group 3 vs. Group 1+2, p=0.007). One patient (0.7%) suffered cardiac death, eight months after recommendation of AVR, and 7 (6.3%) were hospitalized with heart failure. A pO 2 pulse <100% of that predicted was the single predictor of the end-point, odds-ratio 2.55 (95% CI:1.18;5.54) (Table 1). Conclusions: CPX appears useful to separate those with a high probability of improvement with AVR from those, including patients with decreased pVO 2 , with a low event-rate with a conservative approach.


Sign in / Sign up

Export Citation Format

Share Document